# Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically

> **NCT00003664** · PHASE2 · UNKNOWN · sponsor: **Cancer Biotherapy Research Group** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00003664
- **Lead sponsor:** Cancer Biotherapy Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003664, "Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*